IPAS158
Concessão de registro
RPI 2476
06/19/2018
Back to search
Official data from INPI
GYNAZOLE-1
Did you know this trademark is already registered in Brazil?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Registro de marca em vigorType: WordOffice: Brazil
Progress at the INPI
- Filing11/07/15
- Publication11/24/15
- Examination
- Allowance05/08/18
- Grant06/19/18
- In force06/19/28
The registration was granted on 06/19/2018 and is in force until 06/19/2028, when it must be renewed.
Protection valid until:06/19/2028
Latest action published by the INPI: 06/19/2018. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro de marca em vigor
Case type
Application and registration
Recorded events
4
Latest update
06/19/2018
Trademark type
Word
Nice classes
5
Filing date
11/07/2015
Registration date
06/19/2018
Expiration date
06/19/2028
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Produto
Responsible office
Brazil
Owner type
PESSOA JURÍDICA
Owner location
SP, BR
Holders and representatives
Holders
EMS SIGMA PHARMA LTDA
Representatives
BLSA AdvogadosVer perfil do escritório
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicamentos para uso humanoPreparações farmacêuticas
Publications
History of INPI decisions and trademark events.
4 publications found
IPAS029
Deferimento do pedido
RPI 2470
05/08/2018
IPAS423
Notificação de oposição
850160011511 de 20/01/2016
RPI 2360
03/29/2016
IPAS009
Publicação de pedido de registro para oposição (exame formal concluído)
RPI 2342
11/24/2015
EMS SIGMA PHARMA LTDA also protects technology and design at the INPI
1 patent application under the same owner.
Related trademarks
Other trademarks by EMS SIGMA PHARMA LTDA
Similar trademarks
Continuous trademark protection
Get notified about every new filing that threatens GYNAZOLE-1 or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.